TABLE 2.

Qualitative Assessment of Scans

	All included		BR after RP only*		BR after RT only*
Variable	Data	n	Data	n	Data	n
Number of lesions		130		92		35
0	20 (15.4%)		19 (20.7%)		0 (0.0%)
1	53 (40.8%)		35 (38.0%)		18 (51.4%)
2	11 (8.5%)		6 (6.5%)		5 (14.3%)
3	6 (4.6%)		6 (6.5%)		0 (0.0%)
4	3 (2.3%)		3 (3.3%)		0 (0.0%)
5	7 (5.4%)		5 (5.4%)		2 (5.7%)
6–10	14 (10.8%)		10 (10.9%)		3 (8.6%)
>10	16 (12.3%)		8 (8.7%)		7 (20.0%)
Sites of relapse†		130		92		35
Local	35 (26.9%)		13 (14.1%)		22 (62.9%)
Regional nodes	57 (43.8%)		41 (44.6%)		14 (40.0%)
Distant nodes	32 (24.6%)		21 (22.8%)		10 (28.6%)
Bone	26 (20.0%)		20 (21.7%)		6 (17.1%)
Lung	3 (2.3%)		2 (2.2%)		1 (2.9%)
Liver	0 (0.0%)		0 (0.0%)		0 (0.0%)
Other	1 (0.8%)		1 (1.1%)		0 (0.0%)
Diagnosis		130		92		35
Positive	110 (84.6%)		73 (79.3%)		35 (100%)
Negative	20 (15.4%)		19 (20.7%)		0 (0.0%)
Certainty of diagnosis		130		92		35
High	106 (81.5%)		73 (79.3%)		31 (88.6%)
Moderate	17 (13.1%)		14 (15.2%)		3 (8.6%)
Low	7 (5.4%)		5 (5.4%)		1 (2.9%)

^*Inclusion criteria.

^†Categories are not mutually exclusive.

BR = biochemical recurrence; RP = radical prostatectomy; RT = radiation therapy.

Data are proportions.